| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | GREEN ANDREW M SVP, Regulatory and Quality | Sale | -44,001 | -18.85%60,259 | $20.70 | $910,739 | View SEC filing | |
| 2026-03-04 | Horton Amy VP, Chief Accounting Officer | Sale | -901 | -0.64%139,088 | $37.78 | $34,036 | View SEC filing | |
| 2026-03-04 | Holloway Jean F SVP, General Counsel | Sale | -12,805 | -6.47%185,095 | $37.93 | $485,728 | View SEC filing | |
| 2026-03-04 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | -2,149 | -3.45%60,097 | $37.78 | $81,180 | View SEC filing | |
| 2026-03-04 | Davis John E Chief Commercial Officer | Sale | -4,573 | -1.94%230,794 | $37.78 | $172,748 | View SEC filing | |
| 2026-03-04 | Berry Lance A EVP, COO, CFO & Treasurer | Sale | -6,316 | -2.91%210,827 | $37.78 | $238,591 | View SEC filing | |
| 2026-03-04 | Mackin James P President & CEO | Sale | -17,887 | -1.85%947,275 | $37.78 | $675,692 | View SEC filing | |
| 2026-03-03 | Horton Amy VP, Chief Accounting Officer | Sale | -641 | -0.48%132,514 | $38.02 | $24,374 | View SEC filing | |
| 2026-03-03 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | -1,513 | -3.61%40,408 | $38.02 | $57,532 | View SEC filing | |
| 2026-03-03 | Mackin James P President & CEO | Sale | -14,911 | -1.73%848,214 | $38.02 | $566,989 | View SEC filing | |
| 2026-03-03 | Holloway Jean F SVP, General Counsel | Sale | -2,183 | -1.27%170,105 | $38.02 | $83,008 | View SEC filing | |
| 2026-03-03 | Berry Lance A EVP, COO, CFO & Treasurer | Sale | -5,178 | -2.85%176,269 | $38.02 | $196,893 | View SEC filing | |
| 2026-03-03 | Davis John E Chief Commercial Officer | Sale | -2,784 | -1.33%206,522 | $38.02 | $105,861 | View SEC filing | |
| 2026-02-25 | Horton Amy VP, Chief Accounting Officer | Sale | -2,561 | -1.97%127,497 | $36.97 | $94,690 | View SEC filing | |
| 2026-02-25 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | -3,682 | -8.07%41,921 | $36.94 | $136,013 | View SEC filing | |
| 2026-02-25 | Holloway Jean F SVP, General Counsel | Sale | -4,747 | -3.02%152,203 | $36.92 | $175,269 | View SEC filing | |
| 2026-02-25 | Mackin James P President & CEO | Sale | -34,898 | -4.36%766,095 | $36.83 | $1,285,337 | View SEC filing | |
| 2026-02-25 | Berry Lance A EVP, COO, CFO & Treasurer | Sale | -9,466 | -6.17%143,965 | $36.69 | $347,309 | View SEC filing | |
| 2026-02-25 | Davis John E Chief Commercial Officer | Sale | -5,848 | -3.00%188,868 | $36.92 | $215,882 | View SEC filing | |
| 2025-12-17 | Davis John E Chief Commercial Officer | Sale | -5,000 | -2.51%193,842 | $45.11 | $225,550 | View SEC filing | |
| 2025-12-09 | Horton Amy VP, Chief Accounting Officer | Sale | -4,572 | -3.40%130,058 | $44.42 | $203,084 | View SEC filing | |
| 2025-12-04 | Mackin James P President & CEO | Sale | -30,921 | -3.72%800,993 | $45.46 | $1,405,700 | View SEC filing | |
| 2025-12-04 | Holloway Jean F SVP, General Counsel | Sale | -7,315 | -4.48%156,093 | $45.30 | $331,370 | View SEC filing | |
| 2025-12-03 | Mackin James P President & CEO | Sale | -30,921 | -3.72%800,993 | $45.56 | $1,408,730 | View SEC filing | |
| 2025-11-24 | Stanton Marshall S. SVP, Clinical & MD Affair | Sale | -47,376 | -31.21%44,753 | $45.04 | $2,133,920 | View SEC filing |
1-25 of 421
